By Eric Garcia, MarketWatch
WASHINGTON (MarketWatch)--The Securities Exchange Commission announced Thursday night it planned to allow exemptions for a new kind of open end fund that would not need to disclose daily holdings.
The Securities and Exchange Commission on Thursday suspended trade in four over-the-counter Ebola-related stocks: Bravo Enterprises (OGNG) , Immunotech Laboratories (IMMB) , Myriad Interactive Media and Wholehealth Products (GWPC) . The SEC cited a lack of publicly available information about the companies' operations.
By Robbie Whelan , Craig Karmin and Jean Eaglesham
One of the largest U.S. real-estate empires was battered Wednesday by its disclosure of an accounting mistake and subsequent coverup that forced the resignations of two top executives, slashed its flagship company's stock-market value by 19% and sparked a regulatory probe.
Evidence of Los Angeles’ bourgeoning tech scene can be seen in the slew
of marquee start-up success stories, successful IPOs and increased
investor attention that has taken hold of the region in the past year.
CF101 is currently one of the few Oral Drugs developed for Glaucoma A US Patent for the utilization of CF101 for Glaucoma Treatment will be Valid until 2030
The Glaucoma Market Size is estimated to be approximately $3B PETACH TIKVA, Israel , Dec.
Second Sight Medical Products, Inc. (Nasdaq:EYES) (“Second Sight” or
“the Company”), a developer, manufacturer and marketer of implantable
visual prosthetics to restore some functional vision to blind patients,
today announced that it has entered into an exclusive agreement with
distributor Erişçi Elektronik Ltd.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.